**Hassan Bousbaa**

Hassan Bousbaa is a cancer researcher at the Oral Pathology and Rehabilitation Research Unit (UNIPRO) and associate professor of cellular and molecular biology at the Instituto Universitario de ´ Ciencias da Sa ˆ ude—CESPU. Research interests include targeted anticancer therapy; targeting mitosis ´ for cancer therapy; antimitotic agents; biological evaluation of natural and synthetic compounds; and cancer biomarkers. He is acting as a Section Editor of the *Pharmaceutics* journal.
